ALXN
Alexion Pharmaceuticals Inc
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
645 hedge funds and large institutions have $20.1B invested in Alexion Pharmaceuticals Inc in 2019 Q3 according to their latest regulatory filings, with 92 funds opening new positions, 246 increasing their positions, 226 reducing their positions, and 80 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
645
Holders Change
+10
Holders Change %
+1.57%
% of All Funds
14.17%
Holding in Top 10
16
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+33.33%
% of All Funds
0.35%
New
92
Increased
246
Reduced
226
Closed
80
Calls
$176M
Puts
$275M
Net Calls
-$98.9M
Net Calls Change
-$97M
Top Buyers
| 1 |
JPMorgan Chase & Co
New York
|
$467M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
$195M |
| 3 |
PHS
PFM Health Sciences
San Francisco,
California
|
$142M |
| 4 |
D.E. Shaw & Co
New York
|
$160M |
| 5 |
Ninety One (UK)
London,
United Kingdom
|
$196M |
